Not finding it? Sign in to also search OpenAlex live.
-
S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.
Andreas Hochhaus, Andreas Burchert, Susanne Saußele, Gabriela Maria Baerlocher, Jiřı́ Mayer, Tim H. Brümmendorf, +20 more
6citations -
Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of Griffin after 12 Months of Maintenance Therapy
Jonathan L. Kaufman, Jacob P. Laubach, Douglas Weston Sborov, Brandi Reeves, Cesar Rodriguez, Ajai Chari, +21 more
24citations -
A17 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY2021 Journal of the Canadian Association of Gastroenterology article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Laurent Peyrin‐Biroulet, Edward V. Loftus, Silvio Danese, Severine A.R.A. Vermeire, William J. Sandborn, Sandeep Nijhawan, +14 more
12citations -
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study2020 The Lancet Haematology article Medicine Multiple Myeloma Research and Treatments Open access cited by 2 patents
Michèle Cavo, Francesca Gay, Meral Beksaç, Lucia Pantani, Maria Teresa Petrucci, Meletios Athanasios Dimopoulos, +54 more
384citations -
Exploring Patient’s Perspectives and Experiences After Start with Inhalation Maintenance Therapy: A Qualitative Theory-Based Study2020 Patient Preference and Adherence article Pharmacology, Toxicology and Pharmaceutics Pharmacy and Medical Practices Open access
Esther Kuipers, Michel Wensing, Peter A. G. M. De Smet, Martina Teichert
4citations -
Maintenance therapy with subcutaneous immunoglobulin in a patient with immune‐mediated neuropathic postural tachycardia syndrome2021 Journal of Translational Autoimmunity article Medicine Cardiovascular Syncope and Autonomic Disorders Open access
Kalliopi Pitarokoili, Andrea Maier, Elena de Moya Rubio, Katrin Hahn, Gerd Wallukat, Diamantis Athanasopoulos, +4 more
11citations -
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial2022 Intestinal Research article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Toshifumi Hibi∥, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, +10 more
15citations -
Real-World Risk of Myelodysplastic Syndrome/Acute Myeloid Leukemia and Other Second Primary Malignancies in Patients with Epithelial Ovarian Cancer Treated with Niraparib Maintenance Therapy: Results from a Postauthorization Safety Study
Maurice J. D. L. van der Vorst, Constanza Maximiano Alonso, Tirza Areli Calderón Boyle, Jeanne M. Schilder, Izabela A. Malinowska, Guilan Ye, +8 more
0citations -
1192P Characterization of patients with newly diagnosed advanced ovarian cancer not receiving maintenance therapy: Results of a prospective real-world study (NOGGO ov54, SCOUT-1)
Pauline Wimberger, Elena Ioana Braicu, Klaus Pietzner, J. Goldmann, Karol Kubiak, Cosima V. M. Brucker, +14 more
0citations -
Hyperkalemia and maintenance of renin–angiotensin system inhibitor therapy after initiating SGLT-2 or DPP-4 inhibitors2024 Nephrology Dialysis Transplantation article Medicine Diabetes Treatment and Management Open access
Alessandro Bosi, Yang Xu, Anne‐Laure Faucon, Tao Huang, Marie Evans, Jung‐Im Shin, +2 more
5citations -
Real-World Risk Of MDS/AML And Other Secondary Primary Malignancies In Patients With Epithelial Ovarian Cancer Treated With Niraparib Maintenance Therapy: Final Results From A Regulatory Safety Study2025 International Journal of Gynecological Cancer article Medicine Multiple and Secondary Primary Cancers Open access
Constanza Maximiano Alonso, Maurice Van Der Vorst, Tirza Areli Calderón Boyle, Jeanne M. Schilder, Izabela A. Malinowska, Guilan Ye, +6 more
0citations -
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML
Sonia Jaramillo, Johannes Krisam, Lucian Le Cornet, Markus Kratzmann, Lukas Baumann, Tim Sauer, +29 more
7citations -
Dutch ALL11 Study: Improved Outcome for Acute Lymphoblastic Leukemia By Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for ETV6::RUNX1, Down Syndrome and Prednisone Poor Responders
Rob Pieters, Hester A. de Groot‐Kruseman, Femke Verwer, Merian van Overveld, Edwin Sonneveld, Marta F. Fiocco, +10 more
2citations -
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial2024 Journal of Clinical Oncology article Medicine Multiple Myeloma Research and Treatments Open access
Elias Karl Mai, Uta Bertsch, Ema Požek, Roland R. Fenk, Britta Besemer, Christine Hanoun, +71 more
80citations -
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial
Philippe Moreau, Cyrille Hulin, Aurore Perrot, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, +46 more
182citations -
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP‐EBMT study2023 European Journal Of Haematology article Medicine Multiple Myeloma Research and Treatments Open access
Nico Gagelmann, Dirk‐Jan Eikema, Linda Köster, Tanja Netelenbos, Andrew Bruce McDonald, Anne‐Marie Stoppa, +19 more
5citations -
2022-RA-937-ESGO Rucaparib MAintenance after bevacizumab maintenance following carboplatin based chemotherapy in primary ovarian cancer2022 International Journal of Gynecological Cancer article Medicine PARP inhibition in cancer therapy Open access
Elena Ioana Braicu, Klaus Pietzner, Jessica Dysarz, Gunther Rogmans, Pauline Wimberger, EVA KATHARINA EGGER, +13 more
0citations -
TP038/#1408 Rucaparib maintenance after bevacizumab maintenance following carboplatin based first line chemotherapy in ovarian cancer2022 International Journal of Gynecological Cancer article Medicine PARP inhibition in cancer therapy Open access
Jessica Dysarz, Elena Ioana Braicu, Klaus Pietzner, Dario Zocholl, Gunther Rogmans, Pauline Wimberger, +13 more
0citations -
Three‐ and five‐year follow‐up results of a randomized controlled trial on the effects of cognitive behavioral therapy before bariatric surgery2022 International Journal of Eating Disorders article Medicine Bariatric Surgery and Outcomes Open access
Linda Paul, Colin van der Heiden, Daphne van Hoeken, Mathijs L. Deen, Ashley Vlijm, René A. Klaassen, +2 more
15citations -
Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple Myeloma
Christian Straka, Kerstin Schaefer‐Eckart, Bernd Hertenstein, Florian C. Bassermann, Hans Jürgen Salwender, Christian H. Langer, +32 more
17citations